Gene Expression Analysis for the Prediction of Recurrence in Patients with Primary Ta Urothelial Cell Carcinoma

European Urology

Volumn 51, Issue 2, 2007, Pages 416-423

  Schultz, Iman J ^a   Wester, Kenneth ^b   Straatman, Huub ^a   Kiemeney, Lambertus A ^a   Babjuk, Marko ^c   Mares, Jaroslav ^d   Willems, Johannes L ^a   Swinkels, Dorine W ^a   Witjes, J Alfred ^a   Malmström, Per Uno ^b   de Kok, Jacques B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c CHARLES UNIVERSITY   (Czech Republic)

^d CHARLES UNIVERSITY   (Czech Republic)

Author keywords

mRNA expression; Real time quantitative PCR; Recurrence; Ta; Urothelial cell carcinoma

Indexed keywords

MESSENGER RNA; SURVIVIN;

AREA UNDER THE CURVE; ARTICLE; CANCER RECURRENCE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CYSTOSCOPY; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC RECOMBINATION; HUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL SIGNIFICANCE; TUMOR RECURRENCE; URINARY TRACT CARCINOMA; UROTHELIUM;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; RNA, NEOPLASM; URINARY BLADDER NEOPLASMS;

EID: 33845594149     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.07.023     Document Type: Article

References (25)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
2. Botteman M.F., Pashos C.L., Redaelli A., Laskin B., and Hauser R. The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics 21 (2003) 1315-1330
3. Bryan R.T., and Wallace D.M. "Superficial" bladder cancer-time to uncouple pT1 tumours from pTa tumours. BJU Int 90 (2002) 846-852
4. Sauter G., and Mihatsch M.J. Pussycats and baby tigers: non-invasive (pTa) and minimally invasive (pT1) bladder carcinomas are not the same!. J Pathol 185 (1998) 339-341
5. Allard P., Bernard P., Fradet Y., and Tetu B. The early clinical course of primary Ta and T1 bladder cancer: a proposed prognostic index. Br J Urol 81 (1998) 692-698
6. Kiemeney L.A., Witjes J.A., Verbeek A.L., Heijbroek R.P., and Debruyne F.M. The clinical epidemiology of superficial bladder cancer. Dutch South-East Cooperative Urological Group. Br J Cancer 67 (1993) 806-812
7. Abel P.D., Hall R.R., and Williams G. Should pT1 transitional cell cancers of the bladder still be classified as superficial?. Br J Urol 62 (1988) 235-239
8. Heney N.M., Ahmed S., Flanagan M.J., et al. Superficial bladder cancer: progression and recurrence. J Urol 130 (1983) 1083-1086
9. Zieger K., Wolf H., Olsen P.R., and Hojgaard K. Long-term follow-up of noninvasive bladder tumours (stage Ta): recurrence and progression. BJU Int 85 (2000) 824-828
10. Holmang S., Hedelin H., Anderstrom C., Holmberg E., Busch C., and Johansson S.L. Recurrence and progression in low grade papillary urothelial tumors. J Urol 162 (1999) 702-707
11. Bol M.G., Baak J.P., Buhr-Wildhagen S., et al. Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder. J Urol 169 (2003) 1291-1294
12. Tosoni I., Wagner U., Sauter G., et al. Clinical significance of interobserver differences in the staging and grading of superficial bladder cancer. BJU Int 85 (2000) 48-53
13. Ramos D., Navarro S., Villamon R., Gil-Salom M., and Llombart-Bosch A. Cytokeratin expression patterns in low-grade papillary urothelial neoplasms of the urinary bladder. Cancer 97 (2003) 1876-1883
14. Pich A., Chiusa L., Formiconi A., et al. Proliferative activity is the most significant predictor of recurrence in noninvasive papillary urothelial neoplasms of low malignant potential and grade 1 papillary carcinomas of the bladder. Cancer 95 (2002) 784-790
15. Weikert S., Christoph F., Schrader M., Krause H., Miller K., and Muller M. Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis. Int J Cancer 116 (2005) 100-104
16. van Rhijn B.W., Lurkin I., Radvanyi F., Kirkels W.J., van der Kwast T.H., and Zwarthoff E.C. The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate. Cancer Res 61 (2001) 1265-1268
17. Toma V., Hauri D., Schmid U., et al. Focal loss of CD44 variant protein expression is related to recurrence in superficial bladder carcinoma. Am J Pathol 155 (1999) 1427-1432
18. Mostofi FK, Sobin LH, Torloni H. Histologic typing of urinary bladders. In: Anonymous. International histological classification of tumors. Geneva: World Health Organisation; 1973. p. 36.
19. Spiessl B, Beahrs OH, Hermanek P, Hutter RV, Scheibe O, Sobin LH. Anonymous. TNM atlas: illustrated guide to the TNM/pTNM classification of malignant tumors, 3rd ed, 2nd rev. Berlin: Springer-Verlag; 1992. p. 74-279.
20. de Kok J.B., Roelofs R.W., Giesendorf B.A., et al. Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes. Lab Invest 85 (2005) 154-159
21. de Kok J.B., Verhaegh G.W., Roelofs R.W., et al. DD3(PCA3), a very sensitive and specific marker to detect prostate tumors. Cancer Res 62 (2002) 2695-2698
22. Schultz I.J., Kiemeney L.A., Witjes J.A., et al. Survivin mRNA expression is elevated in malignant urothelial cell carcinomas and predicts time to recurrence. Anticancer Res 23 (2003) 3327-3331
23. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-408
24. Eisen M.B., Spellman P.T., Brown P.O., and Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95 (1998) 14863-14868
25. Wild P.J., Herr A., Wissmann C., et al. Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladder. Clin Cancer Res 11 (2005) 4415-4429